Welcome to BlanchardLab - the website for the Laboratory of Emotion and Psychopathology (LEAP). LEAP was established at the University of Maryland, College Park in 1999. Dr. Blanchard directs the lab with the goal of conducting research to better understand how emotion, behavior, and social relations interact to influence the development and maintenance of symptoms in psychotic disorders. The lab studies deficits in motivation and pleasure and related impairments in social affiliation as well as paranoia and the experience of threat in social environments.
LEAP utilizes multiple methods to better understand the diverse factors that contribute to clinical symptoms and social impairment. Current research employs clinical interviews, behavioral assessments, cognitive testing, ecological momentary assessment (EMA) with smartphones, 24-hour actigraphy to track behavior and sleep, and functional magnetic resonance imaging (fMRI). LEAP's research is funded by grants from the National Institute of Mental Health (NIMH), the Veterans Administration, and a University of Maryland Brain and Behavior Initiative seed grant.
Tied to our research is the goal of mentoring undergraduate and graduate students to prepare them for careers in clinical science, applied clinical psychology, and health-related fields. Dr. Blanchard's doctoral students have been supported by NIMH research grants, NIMH institutional and individual training grants, and NIMH Research Supplements to Promote Diversity in Health-Related Research. Former doctoral students have pursued their individual interests and found success in a range of professional roles from academic faculty to applied clinical positions. Reflecting his commitment to training students, Dr. Blanchard has received the Excellence in Teaching and Mentorship Award from the
College of Behavioral and Social Sciences, University of Maryland
LEAP enjoys wonderfully supportive collaborations with other investigators including longstanding connections with the Department of Psychiatry at the University of Maryland School of Medicine. Collaborating researchers provide expertise in neuroscience and neuroimaging, psychosocial interventions, sleep research, and the use of mobile technology to conduct smartphone assessments and behavioral tracking.
Schizophrenia International Research Society
April 6-10 2022
Cohen, A.S., Couture, S.M., & Blanchard, J.J. (2020). Social anhedonia and clinical outcomes in early adulthood: A three-year follow-up study within a community sample. Schizophrenia Research, 223, 213-219.
Dwyer, K.R., Bennett, M.E., & Blanchard, J.J. (2020). Learning the affective value of others in schizophrenia: Examining the role of negative symptoms and cognitive deficits. Journal of Psychopathology and Behavioral Assessment, 42, 714-724.
Dwyer, K, Andrea, A., Savage, C., Orth, R., Shan, L., Strauss, G., Adams, H., Kelly, D., Weiner, E., Gold, J., McMahon, R., Carpenter, W., Buchanan, R., & Blanchard, J.J. (2020). A randomized clinical trial of oxytocin or galantamine in schizophrenia: Assessing the impact on behavioral, lexical, and self-report indicators of social affiliation. Schizophrenia Bulletin Open,
Blanchard, J.J., Savage, C.L., Orth, R.D., Jacome, A.M., Bennett, M.E. (2020). Sleep problems and social impairment in psychosis: A transdiagnostic study examining multiple social domains. Frontiers in Psychiatry.
Blanchard, J.J., Andrea, A., Orth, R., Savage, C., Bennett, M.E. (2020). Sleep disturbance and sleep-related impairment in psychotic disorders are related to both positive and negative symptoms. Psychiatry Research. https://doi.org/10.1016/j.psychres.2020.112857
Blanchard, J.J., Shan, L., Andrea, A., Savage, C., Kring, A.M., Weittenhiller, L. (2020). Negative symptoms and their assessment in schizophrenia and related disorders. In J.C. Badcock & G. Paulik-White (Eds.), Clinical Introduction to Psychosis: Foundations for Clinical and Neuropsychologists (pp 153-176). Elsevier.